A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Maria Escala-Garcia(University of Cambridge), Montserrat García‐Closas(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Angela Cox, Jean Abraham(Cancer Research UK), Hiltrud Brauch(German Cancer Research Center), A. Heather Eliassen(Brigham and Women's Hospital), Natalia Bogdanova(Medizinische Hochschule Hannover), Fergus J. Couch(Mayo Clinic), Miriam Dwek(University of Cambridge), Peter A. Fasching(Universitätsklinikum Erlangen), Jenny Chang‐Claude(Universität Hamburg), Simon S. Cross(University of Sheffield), Suet‐Feung Chin(University of Cambridge), Manuela Gago-Domínguez(University of Southern California), Susan M. Gapstur(Centre international de recherche sur le cancer), William J. Blot(Shanghai Cancer Institute), Sara Y. Brucker(University Children's Hospital Tübingen), Jonine D. Figueroa, Janet Dunn(National Health Service), Päivi Auvinen(University of Eastern Finland), Joe Dennis(University of Cambridge), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Peter Devilee(Leiden University), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Christine L. Clarke(Memorial University of Newfoundland), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Helena Earl(University of Cambridge), D. Gareth Evans(Manchester Academic Health Science Centre), Carlos Caldas(University of Cambridge), Stephen J. Chanock(National Cancer Institute), Carolina Ellberg(Lund University), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Alan Ashworth(University of California, San Francisco), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Mary B. Daly(Fox Chase Cancer Center), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Marina Bermisheva(Russian Academy of Sciences), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Federico Canzian(German Cancer Research Center)
Cited by 48
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k